These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31040711)

  • 1. Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study.
    Kumar KMP; Chawla M; Sanghvi A; Sastry NG; Kotla C; Phatak S; Choudhari S
    Int J Gen Med; 2019; 12():147-159. PubMed ID: 31040711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and Swallowing Experience with a Modified, Smaller-sized Tablet Formulation of Metformin and Glimepiride (SR) in Indian Patients with Type 2 Diabetes Mellitus.
    Modi KD; Farishta F; Phatak S; Godbole SG; Banzal S
    J Assoc Physicians India; 2019 Dec; 67(12):44-49. PubMed ID: 31801331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes.
    Kalra S; Das AK
    J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin extended release: metformin gastric retention, metformin GR, metformin XR.
    Drugs R D; 2005; 6(5):316-9. PubMed ID: 16128603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of extended-release metformin core tablet and synergistic coating of sitagliptin for the treatment of type-II diabetes mellitus - A comparative drug release evaluation with reference product.
    Ahmed A; Wasim AA; Fazal-Ur-Rehman S; Ali M
    Pak J Pharm Sci; 2022 Sep; 35(5):1473-1480. PubMed ID: 36451578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.
    Levy J; Cobas RA; Gomes MB
    Diabetol Metab Syndr; 2010 Mar; 2():16. PubMed ID: 20298568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation.
    Wagstaff AJ; Figgitt DP
    Treat Endocrinol; 2004; 3(5):327-32. PubMed ID: 15330682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
    Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.
    Rotzinger A; Locatelli I; Bugnon O; Fayet Mello A; Parienti JJ; Cavassini M; Schneider MP
    HIV Med; 2016 May; 17(5):390-6. PubMed ID: 26688004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR; Gustavson LE; Devcich KJ; Zhang J; Cao G; Olson CA
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin.
    Oh JH; Eun Lee J; Jeong Kim Y; Oh TO; Han S; Jeon EK; Shin K; Kim DH; Hye Park C; Lee YJ
    Drug Dev Ind Pharm; 2016; 42(2):340-9. PubMed ID: 26467296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
    Hoelscher D; Chu PL; Lyness W
    Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin extended release--DepoMed: metformin, metformin gastric retention, metformin GR.
    Drugs R D; 2004; 5(4):231-3. PubMed ID: 15230631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of extended-release metformin in patients with type 2 diabetes mellitus.
    Jabbour S; Ziring B
    Postgrad Med; 2011 Jan; 123(1):15-23. PubMed ID: 21293080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
    Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.